{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:44:35Z","timestamp":1792799075775,"version":"4.5.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,12,17]],"date-time":"2020-12-17T00:00:00Z","timestamp":1608163200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,12,17]],"date-time":"2020-12-17T00:00:00Z","timestamp":1608163200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000858","name":"University of Sheffield","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000858","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[2021,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>It is 70\u00a0years since Noel Rose embarked on his pioneering studies that lead to the discovery of autoimmune thyroiditis and the elucidation of Hashimoto\u2019s thyroiditis. This short review to honour his passing focuses on the developments in our understanding of the causes and pathogenesis of HT over the last five years. Recent genetic studies have reported heritability estimates for HT and associated diseases for the first time, and emphasised the complexity of the genetic factors involved, including monogenic forms of HT. Environmental factors continue to be elucidated, especially as a side effect of drugs which modulate the immune system therapeutically. Regarding pathogenetic mechanisms, multiple cytokine networks have been identified which involve the thyroid cells in a circuit of escalating proinflammatory effects, such as the expression of inflammasome components, and an array of different defects in T regulatory cells may underlie the loss of self-tolerance to thyroid autoantigens. Finally, a number of studies have revealed fresh insights into disease associations with HT which may have both pathological and clinical significance, the most intriguing of which is a possible direct role of the autoimmune process itself in causing some of the persistent symptoms reported by a minority of patients with levothyroxine-treated HT.<\/jats:p>","DOI":"10.1007\/s40618-020-01477-1","type":"journal-article","created":{"date-parts":[[2020,12,17]],"date-time":"2020-12-17T10:03:54Z","timestamp":1608199434000},"page":"883-890","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":228,"title":["An update on the pathogenesis of Hashimoto\u2019s thyroiditis"],"prefix":"10.1007","volume":"44","author":[{"given":"A. P.","family":"Weetman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,12,17]]},"reference":[{"key":"1477_CR1","doi-asserted-by":"crossref","first-page":"417","DOI":"10.4049\/jimmunol.76.6.417","volume":"76","author":"NR Rose","year":"1956","unstructured":"Rose NR, Witebsky E (1956) Studies on organ specificity. V. Changes in the thyroid glands of rabbits following active immunization with rabbit thyroid extracts. J Immunol 76:417\u2013427","journal-title":"J Immunol"},{"key":"1477_CR2","first-page":"1","volume-title":"Autoimmunity and the thyroid","author":"D Doniach","year":"1985","unstructured":"Doniach D (1985) How autoimmunity was discovered; reminiscences of an autoimmunologist. In: Walfish P, Wall JR, Volp\u00e9 R (eds) Autoimmunity and the thyroid. Academic Press, New York, pp 1\u20138"},{"key":"1477_CR3","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1055\/s-0035-1548832","volume":"47","author":"RA Ajjan","year":"2015","unstructured":"Ajjan RA, Weetman AP (2015) The pathogenesis of Hashimoto\u2019s thyroiditis: further developments in our understanding. Horm Metab Res 47:702\u2013710","journal-title":"Horm Metab Res"},{"key":"1477_CR4","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1530\/EJE-20-0049","volume":"182","author":"J Skov","year":"2020","unstructured":"Skov J, Eriksson D, Kuja-Halkola R, H\u00f6ijer J, Gudbj\u00f6rnsdottir S, Svensson AM, Magnusson PKE, Ludvigsson JF, K\u00e4mpe O, Bensing S (2020) Co-aggregation and heritability of organ-specific autoimmunity: a population-based twin study. Eur J Endocrinol 182:473\u2013480","journal-title":"Eur J Endocrinol"},{"key":"1477_CR5","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1007\/s40618-018-0910-4","volume":"41","author":"A Jabrocka-Hybel","year":"2018","unstructured":"Jabrocka-Hybel A, Skalniak A, Pi\u0105tkowski J, Turek-Jabrocka R, Vyhouskaya P, Ludwig-S\u0142omczy\u0144ska A, Machlowska J, Kapusta P, Ma\u0142ecki M, Pach D, Trofimiuk-M\u00fcldner M, Lizis-Kolus K, Hubalewska-Dydejczyk A (2018) How much of the predisposition to Hashimoto\u2019s thyroiditis can be explained based on previously reported associations? J Endocrinol Invest 41:1409\u20131416","journal-title":"J Endocrinol Invest"},{"key":"1477_CR6","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s40618-018-0955-4","volume":"42","author":"L Br\u010di\u0107","year":"2019","unstructured":"Br\u010di\u0107 L, Bari\u0107 A, Gra\u010dan S, Brekalo M, Kali\u010danin D, Gunja\u010da I, Torlak Lovri\u0107 V, Toki\u0107 S, Radman M, \u0160krabi\u0107 V, Miljkovi\u0107 A, Kol\u010di\u0107 I, \u0160tefani\u0107 M, Glava\u0161-Obrovac L, Lessel D, Pola\u0161ek O, Zemunik T, Barbali\u0107 M, Punda A, Boraska Perica V (2019) Genome-wide association analysis suggests novel loci for Hashimoto\u2019s thyroiditis. J Endocrinol Invest 42:567\u2013576","journal-title":"J Endocrinol Invest"},{"key":"1477_CR7","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/pcmr.12848","volume":"33","author":"GHL Roberts","year":"2020","unstructured":"Roberts GHL, Santorico SA, Spritz RA (2020) The genetic architecture of vitiligo. Pigment Cell Melanoma Res 33:8\u201315","journal-title":"Pigment Cell Melanoma Res"},{"key":"1477_CR8","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jaut.2017.09.003","volume":"86","author":"MS Lo","year":"2018","unstructured":"Lo MS, Towne M, VanNoy GE, Brownstein CA, Lane AA, Chatila TA, Agrawal PB (2018) Monogenic Hashimoto thyroiditis associated with a variant in the thyroglobulin (TG) gene. J Autoimmun 86:116\u2013119","journal-title":"J Autoimmun"},{"key":"1477_CR9","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1136\/annrheumdis-2018-213347","volume":"78","author":"F Berteau","year":"2019","unstructured":"Berteau F, Rouvi\u00e8re B, Nau A, Le Berre R, Sarrabay G, Touitou I, de Moreuil C (2019) A20 haploinsufficiency (HA20): clinical phenotypes and disease course of patients with a newly recognised NF-kB-mediated autoinflammatory disease. Ann Rheum Dis 78:e35","journal-title":"Ann Rheum Dis"},{"key":"1477_CR10","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1089\/thy.2016.0495","volume":"27","author":"RY Zaghlol","year":"2017","unstructured":"Zaghlol RY, Haghighi A, Alkhayyat MM, Theyab OF, Owaydah AM, Massad MM, Atari MA, Zayed AA (2017) Consanguinity and the risk of Hashimoto\u2019s thyroiditis. Thyroid 27:390\u2013395","journal-title":"Thyroid"},{"key":"1477_CR11","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1297\/cpe.28.91","volume":"28","author":"T Hori","year":"2019","unstructured":"Hori T, Ohnishi H, Kadowaki T, Kawamoto N, Matsumoto H, Ohara O, Fukao T (2019) Autosomal dominant Hashimoto\u2019s thyroiditis with a mutation in TNFAIP3. Clin Pediatr Endocrinol 28:91\u201396","journal-title":"Clin Pediatr Endocrinol"},{"key":"1477_CR12","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.3390\/ijms17081369","volume":"17","author":"RH Song","year":"2016","unstructured":"Song RH, Wang Q, Yao QM, Shao XQ, Li L, Wang W, An XF, Li Q, Zhang JA (2016) TNFSF4 gene variations are related to early-onset autoimmune thyroid diseases and hypothyroidism of Hashimoto\u2019s thyroiditis. Int J Mol Sci 17:1369","journal-title":"Int J Mol Sci"},{"key":"1477_CR13","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12902-016-0098-6","volume":"16","author":"Y Wang","year":"2016","unstructured":"Wang Y, Zhu YF, Wang Q, Xu J, Yan N, Xu J, Shi LF, He ST, Zhang JA (2016) The haplotype of UBE2L3 gene is associated with Hashimoto\u2019s thyroiditis in a Chinese Han population. BMC Endocr Disord 16:18","journal-title":"BMC Endocr Disord"},{"key":"1477_CR14","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1159\/000447667","volume":"5","author":"R Negro","year":"2018","unstructured":"Negro R, Attanasio R, Grimaldi F, Marcocci C, Guglielmi R, Papini E (2018) A 2016 Italian Survey about the clinical use of selenium in thyroid disease. Eur Thyroid J 5:164\u2013170","journal-title":"Eur Thyroid J"},{"key":"1477_CR15","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1089\/thy.2016.0256","volume":"26","author":"J Wichman","year":"2016","unstructured":"Wichman J, Winther KH, Bonnema SJ, Heged\u00fcs L (2016) Selenium supplementation significantly reduces thyroid autoantibody levels in patients with chronic autoimmune thyroiditis: a systematic review and meta-analysis. Thyroid 26:1681\u20131692","journal-title":"Thyroid"},{"key":"1477_CR16","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/s41574-019-0311-6","volume":"16","author":"KH Winther","year":"2020","unstructured":"Winther KH, Rayman MP, Bonnema SJ, Heged\u00fcs L (2020) Selenium in thyroid disorders\u2014essential knowledge for clinicians. Nat Rev Endocrinol 16:165\u2013176","journal-title":"Nat Rev Endocrinol"},{"key":"1477_CR17","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1111\/cen.13425","volume":"87","author":"M Thvilum","year":"2017","unstructured":"Thvilum M, Brandt F, Brix TH, Heged\u00fcs L (2017) Month of birth is associated with the subsequent diagnosis of autoimmune hypothyroidism. A nationwide Danish register-based study. Clin Endocrinol (Oxf) 87:832\u2013837","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1477_CR18","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.biopha.2017.08.101","volume":"95","author":"HM Ishaq","year":"2017","unstructured":"Ishaq HM, Mohammad IS, Guo H, Shahzad M, Hou YJ, Ma C, Naseem Z, Wu X, Shi P, Xu J (2017) Molecular estimation of alteration in intestinal microbial composition in Hashimoto\u2019s thyroiditis patients. Biomed Pharmacother 95:865\u2013874","journal-title":"Biomed Pharmacother"},{"key":"1477_CR19","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1089\/thy.2017.0395","volume":"28","author":"F Zhao","year":"2018","unstructured":"Zhao F, Feng J, Li J, Zhao L, Liu Y, Chen H, Jin Y, Zhu B, Wei B (2018) Alterations of the gut microbiota in Hashimoto\u2019s thyroiditis patients. Thyroid 28:175\u2013186","journal-title":"Thyroid"},{"key":"1477_CR20","first-page":"288","volume":"72","author":"WJ Penhale","year":"1988","unstructured":"Penhale WJ, Young PR (1988) The influence of the normal microbial flora on the susceptibility of rats to experimental autoimmune thyroiditis. Clin Exp Immunol 72:288\u2013292","journal-title":"Clin Exp Immunol"},{"key":"1477_CR21","doi-asserted-by":"crossref","first-page":"3678","DOI":"10.1210\/jc.2018-00541","volume":"103","author":"LC Faustino","year":"2018","unstructured":"Faustino LC, Lombardi A, Madrigal-Matute J, Owen RP, Libutti SK, Tomer Y (2018) Interferon-\u03b1 triggers autoimmune thyroid diseases via lysosomal-dependent degradation of thyroglobulin. J Clin Endocrinol Metab 103:3678\u20133687","journal-title":"J Clin Endocrinol Metab"},{"key":"1477_CR22","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/cei.13421","volume":"200","author":"P Urwyler","year":"2020","unstructured":"Urwyler P, Earnshaw I, Bermudez M, Perucha E, Wu W, Ryan S, Mcdonald L, Karagiannis SN, Taams LS, Powell N, Cope A, Papa S (2020) Mechanisms of checkpoint inhibition-induced adverse events. Clin Exp Immunol 200:141\u2013154","journal-title":"Clin Exp Immunol"},{"key":"1477_CR23","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1001\/jamaoncol.2017.3064","volume":"4","author":"R Barroso-Sousa","year":"2018","unstructured":"Barroso-Sousa R, Barry WT, Garrido-Castro AC, Hodi FS, Min L, Krop IE, Tolaney SM (2018) Incidence of endocrine dysfunction following the use of different immune checkpoint inhibitor regimens: a systematic review and meta-analysis. JAMA Oncol 4:173\u2013182","journal-title":"JAMA Oncol"},{"key":"1477_CR24","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1210\/er.2018-00006","volume":"40","author":"LS Chang","year":"2019","unstructured":"Chang LS, Barroso-Sousa R, Tolaney SM, Hodi FS, Kaiser UB, Min L (2019) Endocrine toxicity of cancer immunotherapy targeting immune checkpoints. Endocr Rev 40:17\u201365","journal-title":"Endocr Rev"},{"key":"1477_CR25","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1089\/thy.2020.0075","volume":"30","author":"A Kotwal","year":"2020","unstructured":"Kotwal A, Gustafson MP, Bornschlegl S, Kottschade L, Delivanis DA, Dietz AB, Gandhi M, Ryder M (2020) Immune checkpoint inhibitor-induced thyroiditis is associated with increased intrathyroidal T lymphocyte subpopulations. Thyroid 30:1440\u20131450","journal-title":"Thyroid"},{"key":"1477_CR26","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1002\/cncr.31200","volume":"124","author":"R Barroso-Sousa","year":"2018","unstructured":"Barroso-Sousa R, Ott PA, Hodi FS, Kaiser UB, Tolaney SM, Min L (2018) Endocrine dysfunction induced by immune checkpoint inhibitors: practical recommendations for diagnosis and clinical management. Cancer 124:1111\u20131121","journal-title":"Cancer"},{"key":"1477_CR27","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s40618-019-01105-7","volume":"43","author":"L Scappaticcio","year":"2020","unstructured":"Scappaticcio L, Castellana M, Virili C, Bellastella G, Centanni M, Cannav\u00f2 S, Campenn\u00ec A, Ruggeri RM, Giovanella L, Trimboli P (2020) Alemtuzumab-induced thyroid events in multiple sclerosis: a systematic review and meta-analysis. J Endocrinol Invest 43:219\u2013229","journal-title":"J Endocrinol Invest"},{"key":"1477_CR28","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s00428-015-1893-6","volume":"468","author":"F Jokisch","year":"2016","unstructured":"Jokisch F, Kleinlein I, Haller B, Seehaus T, Fuerst H, Kremer M (2016) A small subgroup of Hashimoto\u2019s thyroiditis is associated with IgG4-related disease. Virchows Arch 468:321\u2013327","journal-title":"Virchows Arch"},{"key":"1477_CR29","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1007\/s12020-015-0662-2","volume":"51","author":"A Rodr\u00edguez-Mu\u00f1oz","year":"2016","unstructured":"Rodr\u00edguez-Mu\u00f1oz A, Vitales-Noyola M, Ramos-Levi A, Serrano-Somavilla A, Gonz\u00e1lez-Amaro R, Marazuela M (2016) Levels of regulatory T cells CD69(+)NKG2D(+)IL-10(+) are increased in patients with autoimmune thyroid disorders. Endocrine 51:478\u2013489","journal-title":"Endocrine"},{"key":"1477_CR30","doi-asserted-by":"crossref","first-page":"3359","DOI":"10.1210\/jc.2018-00498","volume":"103","author":"M Vitales-Noyola","year":"2018","unstructured":"Vitales-Noyola M, Serrano-Somavilla A, Mart\u00ednez-Hern\u00e1ndez R, Sampedro-Nu\u00f1ez M, Ramos-Levi AM, Gonz\u00e1lez-Amaro R, Marazuela M (2018) Patients with autoimmune thyroiditis show diminished levels and defective suppressive function of Tr1 regulatory lymphocytes. J Clin Endocrinol Metab 103:3359\u20133367","journal-title":"J Clin Endocrinol Metab"},{"key":"1477_CR31","doi-asserted-by":"crossref","first-page":"e11211","DOI":"10.1097\/MD.0000000000011211","volume":"97","author":"T Zake","year":"2018","unstructured":"Zake T, Skuja S, Kalere I, Konrade I, Groma V (2018) Heterogeneity of tissue IL-17 and tight junction proteins expression demonstrated in patients with autoimmune thyroid diseases. Medicine (Baltimore) 97:e11211","journal-title":"Medicine (Baltimore)"},{"key":"1477_CR32","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s12020-017-1361-y","volume":"7","author":"M Vitales-Noyola","year":"2017","unstructured":"Vitales-Noyola M, Ramos-Levi AM, Mart\u00ednez-Hern\u00e1ndez R, Serrano-Somavilla A, Sampedro-Nu\u00f1ez M, Gonz\u00e1lez-Amaro R, Marazuela M (2017) Pathogenic Th17 and Th22 cells are increased in patients with autoimmune thyroid disorders. Endocrine 7:409\u2013417","journal-title":"Endocrine"},{"key":"1477_CR33","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.cyto.2014.11.005","volume":"72","author":"LJ Guan","year":"2015","unstructured":"Guan LJ, Wang X, Meng S, Shi LF, Jiang WJ, Xiao L, Shi XH, Xu J, Zhang JA (2015) Increased IL-21\/IL-21R expression and its proinflammatory effects in autoimmune thyroid disease. Cytokine 72:160\u2013165","journal-title":"Cytokine"},{"key":"1477_CR34","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.3389\/fimmu.2018.01197","volume":"9","author":"Q Guo","year":"2018","unstructured":"Guo Q, Wu Y, Hou Y, Liu Y, Liu T, Zhang H, Fan C, Guan H, Li Y, Shan Z, Teng W (2018) Cytokine secretion and pyroptosis of thyroid follicular cells mediated by enhanced NLRP3, NLRP1, NLRC4, and AIM2 inflammasomes are associated with autoimmune thyroiditis. Front Immunol 9:1197","journal-title":"Front Immunol"},{"key":"1477_CR35","doi-asserted-by":"crossref","first-page":"102285","DOI":"10.1016\/j.jaut.2019.05.013","volume":"103","author":"D \u00c1lvarez-Sierra","year":"2019","unstructured":"\u00c1lvarez-Sierra D, Mar\u00edn-S\u00e1nchez A, Ruiz-Bl\u00e1zquez P, de Jes\u00fas GC, Iglesias-Felip C, Gonz\u00e1lez \u00d3, Casteras A, Costa RF, Nuciforo P, Colobran R, Pujol-Borrell R (2019) Analysis of the PD-1\/PD-L1 axis in human autoimmune thyroid disease: Insights into pathogenesis and clues to immunotherapy associated thyroid autoimmunity. J Autoimmun 103:102285","journal-title":"J Autoimmun"},{"key":"1477_CR36","doi-asserted-by":"crossref","first-page":"5853","DOI":"10.4049\/jimmunol.159.12.5853","volume":"159","author":"FM Marelli-Berg","year":"1997","unstructured":"Marelli-Berg FM, Weetman A, Frasca L, Deacock SJ, Imami N, Lombardi G, Lechler RI (1997) Antigen presentation by epithelial cells induces anergic immunoregulatory CD45RO+ T cells and deletion of CD45RA+ T cells. J Immunol 159:5853\u20135861","journal-title":"J Immunol"},{"key":"1477_CR37","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1530\/EJE-19-0424","volume":"181","author":"H Guan","year":"2019","unstructured":"Guan H, de Morais NS, Stuart J, Ahmadi S, Marqusee E, Kim MI, Alexander EK (2019) Discordance of serological and sonographic markers for Hashimoto\u2019s thyroiditis with gold standard histopathology. Eur J Endocrinol 181:539\u2013544","journal-title":"Eur J Endocrinol"},{"key":"1477_CR38","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1507\/endocrj.EJ17-0164","volume":"64","author":"E Nishihara","year":"2017","unstructured":"Nishihara E, Amino N, Kudo T, Ito M, Fukata S, Nishikawa M, Nakamura H, Miyauchi A (2017) Comparison of thyroglobulin and thyroid peroxidase antibodies measured by five different kits in autoimmune thyroid diseases. Endocr J 64:955\u2013961","journal-title":"Endocr J"},{"key":"1477_CR39","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.kjms.2016.06.006","volume":"32","author":"H Bektas Uysal","year":"2016","unstructured":"Bektas Uysal H, Ayhan M (2016) Autoimmunity affects health-related quality of life in patients with Hashimoto\u2019s thyroiditis. Kaohsiung J Med Sci 32:427\u2013433","journal-title":"Kaohsiung J Med Sci"},{"key":"1477_CR40","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1080\/08820139.2018.1529040","volume":"48","author":"A Bari\u0107","year":"2019","unstructured":"Bari\u0107 A, Br\u010di\u0107 L, Gra\u010dan S, \u0160krabi\u0107 V, Brekalo M, \u0160imunac M, Lovri\u0107 VT, Ani\u0107 I, Barbali\u0107 M, Zemunik T, Punda A, Boraska Perica V (2019) Thyroglobulin antibodies are associated with symptom burden in patients with Hashimoto\u2019s thyroiditis: a cross-sectional study. Immunol Invest 48:198\u2013209","journal-title":"Immunol Invest"},{"key":"1477_CR41","doi-asserted-by":"crossref","first-page":"453","DOI":"10.7326\/M18-0284","volume":"170","author":"I Guldvog","year":"2019","unstructured":"Guldvog I, Reitsma LC, Johnsen L, Lauzike A, Gibbs C, Carlsen E, Lende TH, Narvestad JK, Omdal R, Kval\u00f8y JT, Hoff G, Bernklev T, S\u00f8iland H (2019) Thyroidectomy versus medical management for euthyroid patients with Hashimoto disease and persisting symptoms: a randomized trial. Ann Intern Med 170:453\u2013464","journal-title":"Ann Intern Med"},{"key":"1477_CR42","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/cei.12980","volume":"189","author":"T Diana","year":"2017","unstructured":"Diana T, Krause J, Olivo PD, K\u00f6nig J, Kanitz M, Decallonne B, Kahaly GJ (2017) Prevalence and clinical relevance of thyroid stimulating hormone receptor-blocking antibodies in autoimmune thyroid disease. Clin Exp Immunol 189:304\u2013309","journal-title":"Clin Exp Immunol"},{"key":"1477_CR43","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1210\/jc.2016-1220","volume":"101","author":"GJ Kahaly","year":"2016","unstructured":"Kahaly GJ, Diana T, Glang J, Kanitz M, Pitz S, K\u00f6nig J (2016) Thyroid stimulating antibodies are highly prevalent in Hashimoto\u2019s thyroiditis and associated orbitopathy. J Clin Endocrinol Metab 101:1998\u20132004","journal-title":"J Clin Endocrinol Metab"},{"key":"1477_CR44","doi-asserted-by":"crossref","first-page":"100058","DOI":"10.1016\/j.jtauto.2020.100058","volume":"3","author":"H Thomsen","year":"2020","unstructured":"Thomsen H, Li X, Sundquist K, Sundquist J, F\u00f6rsti A, Hemmink K (2020) Familial risks between Graves disease and Hashimoto thyroiditis and other autoimmune diseases in the population of Sweden. J Transl Autoimmun 3:100058","journal-title":"J Transl Autoimmun"},{"key":"1477_CR45","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1530\/EJE-16-0737","volume":"176","author":"RM Ruggeri","year":"2017","unstructured":"Ruggeri RM, Trimarchi F, Giuffrida G, Certo R, Cama E, Campenn\u00ec A, Alibrandi A, De Luca F, Wasniewska M (2017) Autoimmune comorbidities in Hashimoto\u2019s thyroiditis: different patterns of association in adulthood and childhood\/adolescence. Eur J Endocrinol 176:133\u2013141","journal-title":"Eur J Endocrinol"},{"key":"1477_CR46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2016.09.007","volume":"76","author":"CW Li","year":"2017","unstructured":"Li CW, Osman R, Menconi F, Concepcion ES, Tomer Y (2017) Flexible peptide recognition by HLA-DR triggers specific autoimmune T-cell responses in autoimmune thyroiditis and diabetes. J Autoimmun 76:1\u20139","journal-title":"J Autoimmun"},{"key":"1477_CR47","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1007\/s10067-019-04498-1","volume":"38","author":"CE Tagoe","year":"2019","unstructured":"Tagoe CE, Sheth T, Golub E, Sorensen K (2019) Rheumatic associations of autoimmune thyroid disease: a systematic review. Clin Rheumatol 38:1801\u20131809","journal-title":"Clin Rheumatol"},{"key":"1477_CR48","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2500\/ajra.2015.29.4189","volume":"29","author":"PB Degirmenci","year":"2015","unstructured":"Degirmenci PB, Kirmaz C, Oz D, Bilgir F, Ozmen B, Degirmenci M, Colak H, Y\u0131lmaz H, Ozyurt B (2015) Allergic rhinitis and its relationship with autoimmune thyroid diseases. Am J Rhinol Allergy 29:257\u2013261","journal-title":"Am J Rhinol Allergy"},{"key":"1477_CR49","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1007\/s12020-017-1372-8","volume":"57","author":"A Elenkova","year":"2017","unstructured":"Elenkova A, Atanasova I, \u041airilov G, Natchev E, Ivanova R, \u041aovatcheva R, Vandeva S, Tcharaktchiev D, Zacharieva S (2017) Autoimmune hypothyroidism is three times more frequent in female prolactinoma patients compared to healthy women: data from a cross-sectional case-control study. Endocrine 57:486\u2013493","journal-title":"Endocrine"},{"key":"1477_CR50","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s40618-018-0972-3","volume":"42","author":"T Pilli","year":"2019","unstructured":"Pilli T, Cardinale S, Dalmiglio C, Secchi C, Fralassi N, Cevenini G, Di Cairano G, Maino F, Forleo R, Pacini F, Castagna MG (2019) Autoimmune thyroid diseases are more common in patients with prolactinomas: a retrospective case-control study in an Italian cohort. J Endocrinol Invest 42:693\u2013698","journal-title":"J Endocrinol Invest"},{"key":"1477_CR51","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.autrev.2016.09.008","volume":"15","author":"C Laurent","year":"2016","unstructured":"Laurent C, Capron J, Quillerou B, Thomas G, Alamowitch S, Fain O, Mekinian A (2016) Steroid-responsive encephalopathy associated with autoimmune thyroiditis (SREAT): characteristics, treatment and outcome in 251 cases from the literature. Autoimmun Rev 15:1129\u20131133","journal-title":"Autoimmun Rev"},{"key":"1477_CR52","doi-asserted-by":"crossref","first-page":"108350","DOI":"10.1016\/j.clim.2020.108350","volume":"212","author":"W Yang","year":"2020","unstructured":"Yang W, Xiang Y, Zhang H, Shan Z, Li J, Teng W (2020) The role of protein disulphide-isomerase A3 as autoantigen in the pathogenesis of autoimmune thyroiditis and related brain damage in adult mice. Clin Immunol 212:108350","journal-title":"Clin Immunol"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-020-01477-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-020-01477-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-020-01477-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T10:24:49Z","timestamp":1697365489000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-020-01477-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,17]]},"references-count":52,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["1477"],"URL":"https:\/\/doi.org\/10.1007\/s40618-020-01477-1","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,17]]},"assertion":[{"value":"18 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The author has no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals"}},{"value":"No informed consent.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}